Evidence map›Paper›PMID 36631097›Full record

ArticleInternal medicine (Tokyo, Japan)2023

Influence of Nutritional Guidance/Consulting on Glycemic Control during the Coronavirus Disease 2019 Pandemic in Patients with Type 2 Diabetes Mellitus.

Yuichiro Iwamoto, Shuhei Nakanishi, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Tomohiko Kimura, Fuminori Tatsumi, Masashi Shimoda, Tomoatsu Mune and 2 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Yuichiro IwamotoDivision of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan.
Shuhei NakanishiDivision of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan.
Hideyuki IwamotoDivision of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan.
Junpei SanadaDivision of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan.
Yoshiro FushimiDivision of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan.
Yukino KatakuraDivision of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan.
Tomohiko KimuraDivision of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan.
Fuminori TatsumiDivision of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan.
Masashi ShimodaDivision of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan.
Tomoatsu MuneDivision of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan.
Kohei KakuDivision of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan.
Hideaki KanetoDivision of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan.
Kawasaki Medical School Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective The coronavirus disease 2019 (COVID-19) pandemic has led to a global restriction of public behavior due to lockdowns in various major cities. Lifestyle changes and reduced rates of outpatient lifestyle guidance/consulting may have had some impact on glycemic control in patients with type 2 diabetes. This study analyzed the impact of changes in the frequency of nutritional guidance/consulting (NGC) during the COVID-19 pandemic on outpatient care for type 2 diabetes. Methods Among 785 patients, 67 who received regular NGC during the COVID-19 pandemic were assigned to the continuation group (CG), 143 whose NGC was discontinued after the pandemic were assigned to the discontinuation group (DG), and 575 who did not receive regular NGC regardless of the COVID-19 pandemic status were assigned to the irregular NGC group (IGG). The three groups were followed up for two years. Analyses among the three categories were performed using the chi-square test or an analysis of covariance. Results The number of diabetes medications after the declaration of the COVID-19 emergency did not markedly increase in the CG (2.0±1.4 to 2.1±1.5, p>0.05) but significantly increased from 2.2±1.4 to 2.6±1.4 in the DG (p<0.005) and from 2.2±1.4 to 2.4±1.4 in the IGG (p<0.005). The increase in HbA1c adjusted for confounders was unchanged at 0.12±1.06% for the CG and -0.07±1.29% for the IGG but was significantly increased at 0.19±1.49% for the DG (p<0.05). Conclusion In patients with type 2 diabetes mellitus, regular nutritional guidance may be important for maintaining good glycemic control, even during the COVID-19 pandemic.

Indexed as

COVID-19Diabetes Mellitus, Type 2Communicable Disease ControlGlycated HemoglobinGlycemic ControlHumansImmunoglobulin GPandemicsGlycated HemoglobinImmunoglobulin Gcoronavirus disease 2019glycemic controlnutritional guidancepandemictype 2 diabetes mellitus

Identifiers

PMID36631097
PMCPMC10076136
OpenAlexW4315606092

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.